Pen13Lys

General Information


DRACP ID  DRACP02544

Peptide Name   Pen13Lys

Sequence  KIWFQNKKMKWKK

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cell-penetrating peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa WT Human papillomavirus-related endocervical adenocarcinoma Carcinoma 50% Cytotoxicity= μM MTS/PMS assay 1 h 1

Hemolytic Activity  Human erythrocytes: HD50>128 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02544

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C87H137N23O16S

Absent amino acids  ACDEGHLPRSTVY

Common amino acids  K

Mass  200747

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  4

Net charge  6

Boman Index  -3057

Hydrophobicity  -176.92

Aliphatic Index  30

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  11000

Absorbance 280nm  916.67

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23085001

Title  Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure

Doi 10.1016/j.bbamem.2012.10.010

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_8802

DRACP is developed by Dr.Zheng's team.